| Price | 41.00p on 27-03-2025 at 17:30:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 42.00p |
| Sell | 40.00p |
| Buy / Sell EMVC Shares | |
| Last Trade: | Sell 5,000.00 at 40.15p |
| Day's Volume: | 5,002 |
| Last Close: | 41.00p |
| Open: | 41.00p |
| ISIN: | GB00BN4R5Q82 |
| Day's Range | 41.00p - 41.00p |
| 52wk Range: | 40.20p - 80.50p |
| Market Capitalisation: | £11m |
| VWAP: | 40.14994p |
| Shares in Issue: | 28m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Emv Capital (EMVC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 5,000 | 40.15p | Ordinary |
16:15:02 - 27-Mar-25 |
| Sell* | 2 | 40.00p | SI Trade |
08:16:26 - 27-Mar-25 |
| Sell* | 5,577 | 40.50p | Ordinary |
14:32:36 - 26-Mar-25 |
| Sell* | 5,000 | 40.50p | Ordinary |
14:08:01 - 26-Mar-25 |
| Buy* | 14,518 | 41.299p | Ordinary |
11:02:03 - 26-Mar-25 |
| Buy* | 3 | 42.00p | SI Trade |
08:49:38 - 26-Mar-25 |
| Buy* | 4 | 42.00p | SI Trade |
08:49:38 - 26-Mar-25 |
| Buy* | 6 | 42.00p | SI Trade |
08:49:38 - 26-Mar-25 |
| Buy* | 4,833 | 41.299p | Ordinary |
15:10:41 - 25-Mar-25 |
| Sell* | 500 | 40.16p | Ordinary |
15:49:37 - 24-Mar-25 |
Emv Capital (EMVC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Mar 2025 4:46 pm | RNS | PDS: Q4 Results and Clinical Programs Update |
| 7th Mar 2025 4:26 pm | RNS | PDS: VERSATILE-003 Phase 3 Clinical Trial |
| 27th Feb 2025 4:30 pm | RNS | PDS: up to $22mn Registered Direct Offering |
| 5th Feb 2025 3:24 pm | RNS | PDS Biotech reaffirms guidance for clinical trial |
| 3rd Feb 2025 7:00 am | RNS | ProAxsis: Status Update and Proposed Fundraise |
| 6th Jan 2025 4:42 pm | RNS | TR-1 |
| 31st Dec 2024 7:05 am | RNS | Grant of Share Options |
| 31st Dec 2024 7:00 am | RNS | Q-Bot Fundraising |
| 12th Dec 2024 4:49 pm | RNS | TR-1 |
| 9th Dec 2024 7:00 am | RNS | Wanda Health Fundraising |
